Keybanc Initiates Coverage On NeuroPace with Overweight Rating, Announces Price Target of $18
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Keybanc analyst Brett Fishbin initiates coverage on NeuroPace (NASDAQ:NPCE) with a Overweight rating and announces Price Target of $18.
Keybanc analyst Brett Fishbin initiates coverage on NeuroPace (NASDAQ:NPCE) with a Overweight rating and announces Price Target of $18.